Is CRM Stock Really Broken Or Just On Sale?

The market has left this software giant for dead on the price chart, but its financial statements keep telling a story of a business that is very much alive.

The market’s verdict on Salesforce (CRM) is written in plain sight. With the stock trading around $171, about 53% below its two-year high, the implicit message is that this business is impaired. The company that defined cloud-based customer relationship management is now priced as if its best days are decisively behind it. Yet, its cash flow statement offers a powerful, ongoing rebuttal. Is this business actually broken, or just violently marked down?

The cash statement tells a story of health, not distress.

While the stock chart suggests a company in decline, the underlying financial engine is performing at an elite level. Salesforce generates 9.9% of its current market value in free cash flow per year, more than double the 4.1% median for an S&P 500 company. This isn’t a business sacrificing growth for cash, either. Revenue over the last twelve months still grew 11.0%, a continuation of its 10.0% three-year average growth rate.

Profitability is also solid. The company’s operating margin of 22% comfortably exceeds the S&P 500 median of 18.4%. This combination of continued growth, high margins, and exceptional cash generation paints a picture of operational strength, directly contradicting the story of decay told by the stock price.

The market fears the new AI engine cannot outrun a slowing core.

For the markdown to be justified, the market must believe this cash flow is unsustainable. The fear centers on a specific narrative: while the company’s new AI initiatives are showing impressive adoption, they may not be enough to offset weakness in other parts of the business. Management has pointed to “ongoing weakness in marketing and commerce and increased softness in Tableau bookings and renewals.” This disconnect has led some to question if the business is truly faltering despite its lower stock price.

The investor debate, reflected in the latest earnings call, is whether the explosive growth in AI can translate into broad strength for the entire company. While new offerings like Agentforce have surpassed $1 billion in annual recurring revenue, analysts note that key leading indicators of future growth have not consistently outperformed expectations. One concern is that “bookings trends are lagging a little bit,” suggesting the new AI momentum has yet to lift the entire portfolio.

The reacceleration promise is now the only test that matters

The contrarian case rests entirely on management’s ability to prove the doubters wrong. The leadership team has been clear, stating they “expect first-half net new AOV growth to outpace AOV growth” and “drive organic revenue reacceleration in the second half of FY 27.” This is no longer a theoretical debate; it is a specific, time-bound promise.

Therefore, the single most important thing for investors to watch is the progress toward that second-half reacceleration. The next data point will be the company’s performance against its guidance for the upcoming quarter, which includes an expectation for current remaining performance obligation (CRPO) growth of “approximately 13% year over year in constant currency.” For investors who prefer to bet on the broader software theme rather than a single company’s execution, a software ETF like IGV offers diversified exposure. But for Salesforce, hitting or exceeding these near-term growth targets is the only way to prove the cash flow is durable and that the business is not broken, just on sale.

For more stocks priced like decliners while the cash keeps arriving, our Buy the Dip screen runs exactly that screen, every day.

Catching One Falling Knife Is A Gamble. Owning Thirty Handles Is Not

A deep markdown on a cash-generating business is the classic contrarian setup, and the classic way to get hurt: some of these stocks recover, and some deserved every point of the fall. Betting a portfolio on telling one from the other is a hard way to invest.

The Trefis High Quality (HQ) Portfolio takes the same raw material, quality businesses with real cash flow, and spreads the bet across roughly 30 of them, sized and re-balanced with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Watch the wreckage for opportunities; anchor your money to the basket.